{"id":"NCT01167881","sponsor":"Boehringer Ingelheim","briefTitle":"Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes","officialTitle":"A Phase III Randomised, Double-blind, Active-controlled Parallel Group Efficacy and Safety Study of BI 10773 Compared to Glimepiride Administered Orally During 104 Weeks With a 104 Week Extension Period in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control Despite Metformin Treatment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-08","primaryCompletion":"2013-08","completion":"2015-08","firstPosted":"2010-07-22","resultsPosted":"2014-08-08","lastUpdate":"2016-09-02"},"enrollment":1549,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"BI 10773","otherNames":[]},{"type":"DRUG","name":"Glimepiride","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"BI 10773 dose plus metformin","type":"EXPERIMENTAL"},{"label":"Glimepiride 1-4 mg plus metformin","type":"ACTIVE_COMPARATOR"}],"summary":"This is a pivotal phase III study, mandatory to seek approval by regulatory authorities for BI 10773 as an anti-diabetic agent compared to an active comparator in patients with type 2 diabetes mellitus and insufficient glycaemic control.","primaryOutcome":{"measure":"The Change From Baseline in Glycosylated Haemoglobin (HbA1c) After 104 Weeks of Treatment.","timeFrame":"Baseline and 104 weeks","effectByArm":[{"arm":"Empaglifozin 25 mg","deltaMin":-0.66,"sd":0.03},{"arm":"Glimepiride","deltaMin":-0.55,"sd":0.03}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"0.0153"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":10},"locations":{"siteCount":182,"countries":["United States","Argentina","Austria","Canada","Colombia","Czechia","Finland","Hong Kong","India","Italy","Malaysia","Mexico","Netherlands","Norway","Philippines","Portugal","South Africa","Spain","Sweden","Switzerland","Taiwan","Thailand","United Kingdom"]},"refs":{"pmids":["40020703","38770818","33576249","24948511","24007456"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":161,"n":765},"commonTop":["Hyperglycaemia","Hypoglycaemia","Urinary tract infection","Upper respiratory tract infection","Nasopharyngitis"]}}